Skip to main content
NAVCO Pharmaceuticals logo

NAVCO Pharmaceuticals — Investor Relations & Filings

Ticker · NAV ISIN · CA63942R1091 LEI · 8945003WKDH61M8UB963 TSXV Manufacturing
Filings indexed 199 across all filing types
Latest filing 2020-05-01 Regulatory Filings
Country CA Canada
Listing TSXV NAV

About NAVCO Pharmaceuticals

https://www.navcopharma.com/

NAVCO Pharmaceuticals is a biotechnology company specializing in the research, development, and commercialization of nanotechnology products and materials. The company utilizes proprietary Computerized Nano-meter Algorithms to create innovative solutions for anti-viral, anti-fungal, and anti-bacterial treatments. NAVCO focuses on developing supplemental and therapeutic consumer health and wellness products. A key offering is the BioActive™ line, which includes non-toxic, non-flammable, and alcohol-free hand cleansers, creams, and surface disinfectants designed to provide extended protection against germs and microorganisms. These nanotechnology products are marketed across various sectors, including medicine and textiles, providing next-generation protection solutions for multiple industries.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings
2020-05-01 English
Material change report - English.pdf
Regulatory Filings
2020-04-30 English
News release - English.pdf
Regulatory Filings
2020-04-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CFO of BMGB Capital Corp. regarding the interim financial report and interim MD&A for the period ended December 31, 2019. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The text explicitly states it is a certification and does not contain the actual interim financial statements or substantive financial data, but rather attests to the accuracy and fair presentation of those filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (2991 characters), and it is clearly a certification letter, not the full interim report.
2020-02-20 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate. It is a certification by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2019. The document does not contain the actual interim financial statements or substantive financial data but is a certification letter related to those filings. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS) rather than the interim report itself. The document length is short (2980 characters), and it is clearly a certification, not the report itself.
2020-02-20 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Financial Statements' for BMGB Capital Corp. for the period ended December 31, 2019. It contains detailed unaudited financial statements including Statements of Financial Position, Operations and Comprehensive Loss, Changes in Shareholders' Equity, and Cash Flows. The notes describe accounting policies and the basis of preparation under IFRS. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content and format align with an Interim or Quarterly Report, which provides comprehensive financial data for a period shorter than a full fiscal year. Therefore, the document is best classified as an Interim / Quarterly Report (IR). H1 2020
2020-02-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.